Mirna Therapeutics

About:

Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.

Website: http://www.mirnatherapeutics.com

Top Investors: New Enterprise Associates, Correlation Ventures, Rock Springs Capital, OUP (Osage University Partners), Sofinnova Investments

Description:

Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.

Total Funding Amount:

$110M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)mirnatherapeutics.com

Founders:

Matthew Winkler

Number of Employees:

11-50

Last Funding Date:

2015-10-05

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai